Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. (Q43041939)

12 November 2017

title

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

Muratori L

1

1 reference

12 November 2017

Lenzi M

2

1 reference

12 November 2017

Cataleta M

3

1 reference

12 November 2017

Giostra F

4

1 reference

12 November 2017

Cassani F

5

1 reference

12 November 2017

Ballardini G

6

1 reference

12 November 2017

Zauli D

7

1 reference

12 November 2017

Bianchi FB

8

1 reference

12 November 2017

publication date

1 August 1994

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

21

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

199-203

1 reference

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Liver/kidney microsome antibody type 1 and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Counterimmunoelectrophoresis (CIE) for the detection of anti-liver-kidney microsome (LKM) antibodies in the sera of patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Enhanced detection by PCR of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980395-2

7 January 2021

10.1016/S0168-8278(05)80395-2

Identifiers

DOI

1 reference

12 November 2017

1 reference